| Members |
targetComponentId |
| Creation of Gross ileostomy |
Creation of ileostomy |
| Creation of arterioarterial bypass |
Arterial bypass graft |
| Creation of lesion of spinal cord by any modality |
Spinal cord destructive procedure |
| Cremation certification NOS |
Cremation certification status |
| Cremation certification NOS |
Cremation certification |
| Crime inj comp cert NOS |
Criminal injury compensation board certification status |
| Crime inj comp cert NOS |
Criminal injury compensation board certification status |
| Crimean fever |
Congo-Crimean hemorrhagic fever (disorder) |
| Critical care physician services |
Critical care physician service (qualifier value) |
| Cromoglycate and related antiallergenic allergy |
Allergy to cromoglicic acid (finding) |
| Cromolyn sodium 0.8mg/spray |
Sodium cromoglicate 800 microgram/actuation powder for inhalation |
| Cromolyn sodium 8.1g spray |
Sodium cromoglicate 800 microgram/actuation powder for inhalation |
| Cross-linked hyaluronic acid 24mg/mL injection gel |
Hyaluronic acid only product in parenteral dose form |
| Crown heel length |
Recumbent body height (observable entity) |
| Crown, full cast high noble metal |
Restoration of tooth with full coverage noble metal crown (procedure) |
| Crown, full cast noble metal |
Restoration of tooth with full coverage noble metal crown (procedure) |
| Crown, porcelain fused to high noble metal |
Restoration of tooth using porcelain fused to noble metal crown |
| Crown, porcelain fused to noble metal |
Restoration of tooth using porcelain fused to noble metal crown |
| Crown, resin with high noble metal |
Restoration of tooth with resin and noble metal crown (procedure) |
| Crown, resin with noble metal |
Restoration of tooth with resin and noble metal crown (procedure) |
| Cruelty |
Cruel behavior |
| Crush injury, trunk NOS |
Crushing injury of trunk |
| Crush injury, trunk NOS |
Crushing injury of trunk |
| Crushing injury NOS |
Crushing injury (disorder) |
| Crushing injury NOS |
Crushing injury (disorder) |
| Crushing injury of multiple sites of shoulder AND/OR upper arm (disorder) |
Crushing injury of multiple sites of upper limb |
| Crushing injury of multiple sites, NEC |
Crushing injury of multiple sites |
| Crustacean |
Subphylum Crustacea (organism) |
| Crutches |
Crutch |
| Cryosurgery to lesion of female perineum |
Cryosurgery to lesion of perineum (procedure) |
| Cryotherapy to lesion of organ NOC |
Cryotherapy |
| Cryotherapy to organ NOC |
Cryotherapy |
| Cryotherapy to organ NOC NOS |
Cryotherapy |
| Cryotherapy to organ NOC OS |
Cryotherapy |
| Cryptococcus albidus variant albidus |
Naganishia albida (organism) |
| Cryptococcus antigen level |
Cryptococcus species antigen assay |
| Cryptococcus antigen level |
Cryptococcus species antigen assay |
| Cryptococcus antigen level |
Cryptococcus species antigen assay |
| Cryptococcus neoformans var gattii |
Cryptococcus gattii (organism) |
| Cryptogenic |
Unknown (origin) |
| Cryptogenic Lennox-Gastaut syndrome |
Lennox-Gastaut syndrome |
| Cryptogenic West syndrome |
Infantile epileptic spasms syndrome (disorder) |
| Cryptogenic generalized epilepsy |
Generalized epilepsy |
| Cryptogenic myoclonic epilepsy |
Generalized epilepsy |
| Crystal arthropathy NOS |
Crystal arthropathy |
| Crystal arthropathy NOS |
Crystal arthropathy |
| Crystal arthropathy of other site |
Crystal arthropathy |
| Crystal violet tattoo |
Crystal violet tattoo |
| Cucumber - dietary |
Cucumber (substance) |
| Cucumovirus group |
Genus Cucumovirus (organism) |
| Curettage of lesion of organ NOC |
Curettage |
| Curettage of organ NOC |
Curettage |
| Curettage of organ NOC NOS |
Curettage |
| Curettage of organ NOC OS |
Curettage |
| Curettage of products of conception from uterus NEC |
Dilation of cervix uteri and curettage of products of conception from uterus |
| Curettage products conception: [uterus NEC (& retained)] or [termination NEC] |
Dilation of cervix uteri and curettage of products of conception from uterus |
| Curvature of spine NOS |
Curvature of spine |
| Curvature of spine NOS |
Curvature of spine |
| Curvature of stomach |
Stomach part |
| Cutaneous CD30+ lymphoproliferative disorder |
Primary cutaneous CD30+ large T-cell lymphoma |
| Cutaneous T-cell lymphoma, no International Classification of Diseases for Oncology subtype |
Cutaneous T-cell lymphoma |
| Cutaneous anaphylaxis |
Localized anaphylaxis |
| Cutaneous eruption |
Eruption |
| Cutaneous larva migrans NOS |
Cutaneous larva migrans |
| Cutaneous larva migrans NOS |
Cutaneous larva migrans |
| Cyanocobalamin 25micrograms nasal spray |
Product containing only cyanocobalamin in nasal dose form (medicinal product form) |
| Cyanocobalamin 500mcg nasal spray |
Cyanocobalamin 500 microgram/actuation nasal spray |
| Cyanocobalamin[57Co] 370kBq/mL oral solution |
Cyanocobalamin (57-Co) only product in oral dose form |
| Cyanocobalamin[58Co] 370kBq/mL oral solution |
Product containing only cyanocobalamin (58-Co) in oral dose form (medicinal product form) |
| CyberKnife |
Robotic radiation delivery system |
| Cyclic edema |
Edema |
| Cycloanemization |
Destruction of ciliary body |
| Cyclopentolate hydrochloride + phenylephrine hydrochloride |
Product containing cyclopentolate and phenylephrine (medicinal product) |
| Cyclopentolate hydrochloride 0.5% conventional release eye drops |
Cyclopentolate hydrochloride 5 mg/mL eye solution |
| Cyclopentolate hydrochloride 0.5% single-use eye drops |
Cyclopentolate hydrochloride 5 mg/mL eye solution |
| Cyclopentolate hydrochloride 1% conventional release eye drops |
Cyclopentolate hydrochloride 10 mg/mL eye solution |
| Cyclopentolate hydrochloride 1% single-use eye drops |
Cyclopentolate hydrochloride 10 mg/mL eye solution |
| Cyclopentolate hydrochloride 2% eye drops |
Cyclopentolate hydrochloride 20 mg/mL eye solution |
| Cyclophosphamide 1g/vial injection |
Cyclophosphamide 1 g powder for solution for injection vial |
| Cyclophosphamide 1g/vial powder for injection |
Cyclophosphamide 1 g powder for solution for injection vial |
| Cyclophosphamide 200mg/vial injection |
Cyclophosphamide 200 mg powder for solution for injection vial |
| Cyclophosphamide 200mg/vial powder for injection |
Cyclophosphamide 200 mg powder for solution for injection vial |
| Cyclophosphamide 2g/vial injection |
Product containing precisely cyclophosphamide 2 gram/1 vial powder for conventional release solution for injection (clinical drug) |
| Cyclophosphamide 500mg/vial injection |
Cyclophosphamide 500 mg powder for solution for injection vial |
| Cyclophosphamide 500mg/vial powder for injection |
Cyclophosphamide 500 mg powder for solution for injection vial |
| Cyclopropane [no agents] |
Cyclopropane |
| Cyclosporin 50mg/1mL oily infusion concentrate |
Product containing precisely ciclosporin 50 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Cyclosporine 100mg/5mL solution |
Product containing only ciclosporin (medicinal product) |
| Cyclosporine 100mg/mL solution |
Ciclosporin 100 mg/mL oral solution |
| Cyclosporine 50mg gel |
Ciclosporin 50 mg oral capsule |
| Cyclosporine ophthalmic emulsion 0.05% |
Product containing precisely ciclosporin 500 microgram/1 milliliter conventional release eye suspension (clinical drug) |
| Cylindrical cell papilloma uncertain whether benign or malignant |
Oncocytic Schneiderian papilloma of uncertain behavior (morphologic abnormality) |
| Cylindrocarpon tonkinense |
Neocosmospora lichenicola (organism) |
| Cyproheptadine hydrochloride 2mg/5mL oral syrup |
Product containing precisely cyproheptadine hydrochloride 400 microgram/1 milliliter conventional release oral solution (clinical drug) |
| Cyst of bursa |
Bursal cyst |
| Cyst of testes |
Cyst of testis (disorder) |
| Cysteamine 0.1% eye drops |
Product containing precisely mercaptamine 1 milligram/1 milliliter conventional release eye solution (clinical drug) |
| Cysteine carboxypeptidase |
Cysteine carboxypeptidase |
| Cysteine proteinase |
Cysteine proteinase |
| Cystic fibrosis with other manifestations |
Cystic fibrosis |
| Cystic fibrosis with other manifestations |
Cystic fibrosis |